Pioneering cellular rejuvenation, HeXemBio developed the first regenerative therapy for hematopoietic stem cells, with transformative potential in transplant failure, aging, and longevity. Their platform is safe, scalable, and clinically disruptive.

Hyper-focused on scaling regenerative wound care medicine, bridging the gap between basic bandages and advanced cell therapy through the world's most scalable, resilient, and versatile tissue regeneration matrix.

Fecundis transforms access to fertility treatments, providing affordable and effective solutions to improve reproductive health. With innovative technology and a human approach, it seeks to increase success rates and availability.

Axenya integrates advanced technology and health insurance to improve chronic disease care, optimizing patient experience and reducing costs, with a comprehensive focus on the health ecosystem.

ViewMind uses AI-driven eye-tracking to detect and monitor neurocognitive conditions like Alzheimer's and Parkinson's non-invasively.

Xeptiva Therapeutics develops innovative immunotherapies for chronic inflammation in pets, focusing on enhancing their healthspan with first-in-class therapeutic vaccines.

Biomakers transforms genomic data into therapeutic decisions, specializing in personalized treatments through genomic testing and partnerships for access to complex drugs, operating in Latin America.

Through science and bioengineering, Harmony is disrupting the infant nutrition industry, by developing formulas to replace cow's milk with easy, healthy, ethical and sustainable solutions.

ISA is a digital health services platform that simplifies the delivery of healthcare solutions to patients wherever they are.

Has developed Mask, a natural ingredient specifically designed to enable food and beverage companies to produce incredibly tasty zero-sugar and vegan alternatives by effectively eliminating unwanted off-notes and aftertastes.

AI-powered solutions for respiratory disease diagnosis and management.

A safe, non-invasive treatment for patients with advanced cancer that consists of applying specific electromagnetic frequencies to improve the results of standard oncology treatment. 

Integrates artificial intelligence algorithms, low-cost genomic sequencing and remote medicine to detect cardiovascular diseases anywhere in the world.